Mycrodose Therapeutics Expands Scientific Advisory Board with the Addition of Dr. Yavorsky and Dr. Jacques

San Diego, California--(Newsfile Corp. - December 14, 2021) - Mycrodose Therapeutics ("Mycrodose"), a leading US pharmaceutical company developing advanced drug delivery technologies for use with psychedelic

Related Keywords

State Of California ,California ,United States ,San Diego ,Kostenloser Wertpapierhandel ,Thorne Healthtech ,Jacqueline Jacques ,Patrick Eckstrom ,Christian Yavorsky ,Research Advisory Board ,United States Drug Enforcement Agency ,Microdosing Technology ,Obesity Society ,California Naturopathic Doctors Association ,Samueli Integrative Health Institute ,Obesity Action Coalition ,Companies Of Johnson ,California Newsfile Corp ,Us Food Drug Administration ,Bodywise International ,Scientific Advisory ,Pharmaceutical Companies ,Rapid Acting Antidepressant ,Executive Team ,Chad Conner ,Mycrodose Therapeutics ,Naturopathic Doctor ,Chief Medical Officer ,Alkemist Labs ,California Naturopathic Doctors ,Mycrodose Therapeutic Scientific ,Schedulei License ,California Attorney General ,Drug Administration ,Protected Sustained Microdosing Technology ,Mycrodose ,Herapeutics ,Xpands ,Cientific ,Advisory ,Board ,Addition ,Avorsky ,Acques ,